Uncontrolled and high-impact pain were linked to an increased risk for OUD and opioid overdose among older adults prescribed opioids.

Halneuron, a NaV 1.7 sodium channel inhibitor, is being tested for chemotherapy-induced neuropathic pain, offering a potential opioid alternative. Previous trials showed Halneuron significantly ...